<!DOCTYPE html>
<html lang="en" dir="auto">

<head>
<head>
    <title>pathology</title>
    <meta charset="utf-8">
    <meta name="description"
        content="Website meta description for google search results go here" />
    <meta name="dc.relation" content="https://trxiv.yorks0n.com" />
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <meta name="theme-color" content="#1A94D2" />

    

    
    
    
    <link rel="stylesheet" href="/css/main.min.css" media="screen">

</head>


<meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>pathology | TRxiv2</title>
<meta name="keywords" content="">
<meta name="description" content="Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology
Authors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.
Score: 12.8, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878
Lewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity.">
<meta name="author" content="">
<link rel="canonical" href="https://trxiv.yorks0n.com/posts/pathology/">
<link crossorigin="anonymous" href="/assets/css/stylesheet.904bd1e751cdd2a584fa6bed3fa1166dfd8ec9949ebfd0c4d69c5add5e17c23d.css" integrity="sha256-kEvR51HN0qWE&#43;mvtP6EWbf2OyZSev9DE1pxa3V4Xwj0=" rel="preload stylesheet" as="style">
<script defer crossorigin="anonymous" src="/assets/js/highlight.f413e19d0714851f6474e7ee9632408e58ac146fbdbe62747134bea2fa3415e0.js" integrity="sha256-9BPhnQcUhR9kdOfuljJAjlisFG&#43;9vmJ0cTS&#43;ovo0FeA="
    onload="hljs.initHighlightingOnLoad();"></script>
<link rel="icon" href="https://trxiv.yorks0n.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://trxiv.yorks0n.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://trxiv.yorks0n.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://trxiv.yorks0n.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://trxiv.yorks0n.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --hljs-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:title" content="pathology" />
<meta property="og:description" content="Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology
Authors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.
Score: 12.8, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878
Lewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity." />
<meta property="og:type" content="article" />
<meta property="og:url" content="https://trxiv.yorks0n.com/posts/pathology/" /><meta property="article:section" content="posts" />
<meta property="article:published_time" content="2023-12-10T10:37:48+00:00" />
<meta property="article:modified_time" content="2023-12-10T10:37:48+00:00" />

<meta name="twitter:card" content="summary"/>
<meta name="twitter:title" content="pathology"/>
<meta name="twitter:description" content="Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology
Authors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.
Score: 12.8, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878
Lewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity."/>


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "Posts",
      "item": "https://trxiv.yorks0n.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  3 ,
      "name": "pathology",
      "item": "https://trxiv.yorks0n.com/posts/pathology/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "pathology",
  "name": "pathology",
  "description": "Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology\nAuthors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.\nScore: 12.8, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878\nLewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity.",
  "keywords": [
    
  ],
  "articleBody": " Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology\nAuthors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.\nScore: 12.8, Published: 2023-12-07 DOI: 10.1101/2023.12.05.569878\nLewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity. This may be due to variations in accumulation patterns of LB neuropathology. By applying data-driven disease progression modelling to regional neuropathological LB density scores from 814 brain donors, we describe three inferred trajectories of LB pathology that were characterized by differing clinicopathological presentation and longitudinal antemortem clinical progression. Most donors (81.9%) showed earliest pathology in the olfactory bulb, followed by accumulation in either limbic (60.8%) or brainstem (21.1%) regions. The remaining donors (18.1%) exhibited the first abnormalities in brainstem regions. Early limbic pathology was associated with Alzheimers disease-associated characteristics. Meanwhile, brainstem-first pathology was associated with progressive motor impairment and substantial LB pathology outside of the brain. Our data provides evidence for heterogeneity in the temporal spread of LB pathology, possibly explaining some of the clinical disparities observed in LBDs.\nUBE2N is essential for maintenance of skin homeostasis and suppression of inflammation\nAuthors: Lee, M. J.; Ben Hammouda, M.; Miao, W.; Okafor, A.; Jin, Y.; Sun, H.; Jain, V.; Markovtsov, V.; Diao, Y.; Gregory, S. G.; Zhang, J. Y.\nScore: 1.2, Published: 2023-12-04 DOI: 10.1101/2023.12.01.569631\nUBE2N, a Lys63-ubiquitin conjugating enzyme, plays critical roles in embryogenesis and immune system development and function. However, its roles in adult epithelial tissue homeostasis and pathogenesis are unclear. We generated conditional mouse models that deleted Ube2n in skin cells in a temporally and spatially controlled manner. We found that Ube2n- knockout (KO) in the adult skin keratinocytes induced a range of inflammatory skin defects characteristic of psoriatic and actinic keratosis. These included eczematous inflammation, epidermal and dermal thickening, parakeratosis, and increased immune cell infiltration, as well as signs of edema and blistering. Single cell transcriptomic analyses and RT-qPCR showed that Ube2n KO keratinocytes expressed elevated myeloid cell chemo-attractants such as Cxcl1 and Cxcl2 and decreased the homeostatic T lymphocyte chemo-attractant, Ccl27a. Consistently, the infiltrating immune cells of Ube2n-KO skin were predominantly myeloid-derived cells including neutrophils and M1-like macrophages that were highly inflammatory, as indicated by expression of Il1{beta} and Il24. Pharmacological blockade of the IL-1 receptor associated kinases (IRAK1/4) alleviated eczema, epidermal and dermal thickening, and immune infiltration of the Ube2n mutant skin. Together, these findings highlight a key role of keratinocyte-UBE2N in maintenance of epidermal homeostasis and skin immunity and identify IRAK1/4 as potential therapeutic target for inflammatory skin disorders.\nXanthomonas euvesicatoria effector XeAvrRxo1 triggers a Rxo1-mediated defense response in Nicotiana benthamiana and its chaperone Xe4429 functions as an antitoxin, an expression repressor, and an enhancer of XeAvrRxo1 secretion\nAuthors: Wang, Z.; Zhou, C.; Roach, T. G.; Li, Q.; Wang, K.; Miao, J.; Toro, C.; Wu, S.; Tang, Y.; Han, Q.; Sun, F.; Capelluto, D.; Li, J.; Zhao, B.\nScore: 1.0, Published: 2023-12-04 DOI: 10.1101/2023.12.02.569727\nXanthomonas euvesicatoria (X. euvesicatoria) is the causal agent of bacterial spot disease that threatens pepper and tomato production around the globe. X. euvesicatoria gene Xe4428 encodes a type III effector (T3E) that shares 89.67% amino acid identity with Xanthomonas oryzae pv. oryzicola (Xoc) T3E AvrRxo1. Deletion of Xe4428 in the genome of X. euvesicatoria (strain Xcv85-10) compromised its virulence to infect pepper and Nicotiana benthamiana plants. Transient co-expression of Xe4428 and Rxo1 on pepper and N. benthamiana plant leaves results in a robust hypersensitive reaction. Thus, Xe4428, renamed as XeAvrRxo1, is a bona fide orthologue of XocAvrRxo1 that possesses both virulence and avirulence functions. Expression of XeAvrRxo1 in E. coli and X. euvesicatoria is toxic to both bacterial cells. Another X. euvesicatoria gene Xe4429, encodes a putative chaperone of XeAvrRxo1, which can interact with XeAvrRxo1 to suppress its toxicity in X. euvesicatoria and E. coli bacterial cells. Xe4429 also binds to the promoter region of XeavrRxo1 and represses its transcription/translation in X. euvesicatoria bacterial cells. In addition, expression of Xe4429 can enhance the secretion and translocation of XeAvrRxo1 into plant cells. Therefore, Xe4429 functions as an antitoxin, a transcription repressor, and a type III chaperone that is capable of enhancing the secretion and translocation of XeAvrRxo1 during pathogenesis.\n",
  "wordCount" : "730",
  "inLanguage": "en",
  "datePublished": "2023-12-10T10:37:48Z",
  "dateModified": "2023-12-10T10:37:48Z",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://trxiv.yorks0n.com/posts/pathology/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "TRxiv2",
    "logo": {
      "@type": "ImageObject",
      "url": "https://trxiv.yorks0n.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://trxiv.yorks0n.com" accesskey="h" title="TRxiv2 (Alt + H)">TRxiv2</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
        </ul>
    </nav>
</header>
<main class="main">
<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title">
      pathology
    </h1>
    <div class="post-meta">&lt;span&gt;updated on December 10, 2023&lt;/span&gt;

</div>
  </header> 
  <div class="post-content"><div class="accordion accordion-flush" id="accordionFlushExample"><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.05.569878">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.05.569878" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.05.569878">
        <p class="paperTitle">Disease progression modelling reveals heterogeneity in trajectories of Lewy-type alpha-synuclein pathology</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.05.569878" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.05.569878" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Mastenbroek, S. E.; Vogel, J. W.; Collij, L. E.; Serrano, G. E.; Tremblay, C.; Young, A. L.; Arce, R. A.; Shill, H. A.; Driver-Dunckley, E. D.; Mehta, S. H.; Belden, C. M.; Atri, A.; Choudhury, P.; Barkhof, F.; Adler, C. H.; Ossenkoppele, R.; Beach, T. G.; Hansson, O.</p>
        <p class="info">Score: 12.8, Published: 2023-12-07 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.05.569878' target='https://doi.org/10.1101/2023.12.05.569878'> 10.1101/2023.12.05.569878</a></p>
        <p class="abstract">Lewy body (LB) disorders, characterized by the aggregation of misfolded -synuclein proteins, exhibit notable clinical heterogeneity. This may be due to variations in accumulation patterns of LB neuropathology. By applying data-driven disease progression modelling to regional neuropathological LB density scores from 814 brain donors, we describe three inferred trajectories of LB pathology that were characterized by differing clinicopathological presentation and longitudinal antemortem clinical progression. Most donors (81.9%) showed earliest pathology in the olfactory bulb, followed by accumulation in either limbic (60.8%) or brainstem (21.1%) regions. The remaining donors (18.1%) exhibited the first abnormalities in brainstem regions. Early limbic pathology was associated with Alzheimers disease-associated characteristics. Meanwhile, brainstem-first pathology was associated with progressive motor impairment and substantial LB pathology outside of the brain. Our data provides evidence for heterogeneity in the temporal spread of LB pathology, possibly explaining some of the clinical disparities observed in LBDs.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.01.569631">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.01.569631" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.01.569631">
        <p class="paperTitle">UBE2N is essential for maintenance of skin homeostasis and suppression of inflammation</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.01.569631" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.01.569631" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Lee, M. J.; Ben Hammouda, M.; Miao, W.; Okafor, A.; Jin, Y.; Sun, H.; Jain, V.; Markovtsov, V.; Diao, Y.; Gregory, S. G.; Zhang, J. Y.</p>
        <p class="info">Score: 1.2, Published: 2023-12-04 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.01.569631' target='https://doi.org/10.1101/2023.12.01.569631'> 10.1101/2023.12.01.569631</a></p>
        <p class="abstract">UBE2N, a Lys63-ubiquitin conjugating enzyme, plays critical roles in embryogenesis and immune system development and function. However, its roles in adult epithelial tissue homeostasis and pathogenesis are unclear. We generated conditional mouse models that deleted Ube2n in skin cells in a temporally and spatially controlled manner. We found that Ube2n- knockout (KO) in the adult skin keratinocytes induced a range of inflammatory skin defects characteristic of psoriatic and actinic keratosis. These included eczematous inflammation, epidermal and dermal thickening, parakeratosis, and increased immune cell infiltration, as well as signs of edema and blistering. Single cell transcriptomic analyses and RT-qPCR showed that Ube2n KO keratinocytes expressed elevated myeloid cell chemo-attractants such as Cxcl1 and Cxcl2 and decreased the homeostatic T lymphocyte chemo-attractant, Ccl27a. Consistently, the infiltrating immune cells of Ube2n-KO skin were predominantly myeloid-derived cells including neutrophils and M1-like macrophages that were highly inflammatory, as indicated by expression of Il1{beta} and Il24. Pharmacological blockade of the IL-1 receptor associated kinases (IRAK1/4) alleviated eczema, epidermal and dermal thickening, and immune infiltration of the Ube2n mutant skin. Together, these findings highlight a key role of keratinocyte-UBE2N in maintenance of epidermal homeostasis and skin immunity and identify IRAK1/4 as potential therapeutic target for inflammatory skin disorders.</p>
      </div>
    </div>
  </div><div class="accordion-item">
    <h3 class="accordion-header" id="flush-heading10.1101/2023.12.02.569727">
      <button class="accordion-button collapsed" type="button" data-bs-toggle="collapse" data-bs-target="#flush-collapse10.1101/2023.12.02.569727" aria-expanded="false" aria-controls="flush-collapse10.1101/2023.12.02.569727">
        <p class="paperTitle">Xanthomonas euvesicatoria effector XeAvrRxo1 triggers a Rxo1-mediated defense response in Nicotiana benthamiana and its chaperone Xe4429 functions as an antitoxin, an expression repressor, and an enhancer of XeAvrRxo1 secretion</p>
      </button>
    </h3>
    <div id="flush-collapse10.1101/2023.12.02.569727" class="accordion-collapse collapse" aria-labelledby="flush-heading10.1101/2023.12.02.569727" data-bs-parent="#accordionFlushExample">
      <div class="accordion-body">
        <p class="author">Authors: Wang, Z.; Zhou, C.; Roach, T. G.; Li, Q.; Wang, K.; Miao, J.; Toro, C.; Wu, S.; Tang, Y.; Han, Q.; Sun, F.; Capelluto, D.; Li, J.; Zhao, B.</p>
        <p class="info">Score: 1.0, Published: 2023-12-04 </p>
        <p class="info">DOI: <a href='https://doi.org/10.1101/2023.12.02.569727' target='https://doi.org/10.1101/2023.12.02.569727'> 10.1101/2023.12.02.569727</a></p>
        <p class="abstract">Xanthomonas euvesicatoria (X. euvesicatoria) is the causal agent of bacterial spot disease that threatens pepper and tomato production around the globe. X. euvesicatoria gene Xe4428 encodes a type III effector (T3E) that shares 89.67% amino acid identity with Xanthomonas oryzae pv. oryzicola (Xoc) T3E AvrRxo1. Deletion of Xe4428 in the genome of X. euvesicatoria (strain Xcv85-10) compromised its virulence to infect pepper and Nicotiana benthamiana plants. Transient co-expression of Xe4428 and Rxo1 on pepper and N. benthamiana plant leaves results in a robust hypersensitive reaction. Thus, Xe4428, renamed as XeAvrRxo1, is a bona fide orthologue of XocAvrRxo1 that possesses both virulence and avirulence functions. Expression of XeAvrRxo1 in E. coli and X. euvesicatoria is toxic to both bacterial cells. Another X. euvesicatoria gene Xe4429, encodes a putative chaperone of XeAvrRxo1, which can interact with XeAvrRxo1 to suppress its toxicity in X. euvesicatoria and E. coli bacterial cells. Xe4429 also binds to the promoter region of XeavrRxo1 and represses its transcription/translation in X. euvesicatoria bacterial cells. In addition, expression of Xe4429 can enhance the secretion and translocation of XeAvrRxo1 into plant cells. Therefore, Xe4429 functions as an antitoxin, a transcription repressor, and a type III chaperone that is capable of enhancing the secretion and translocation of XeAvrRxo1 during pathogenesis.</p>
      </div>
    </div>
  </div>
</div>









<script src="/js/bundle.min.js" defer></script>



  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
    <span>&copy; 2023 <a href="https://trxiv.yorks0n.com">TRxiv2</a></span>
    <span>
        · Made by Yorkson
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
